Mylan Pharmaceuticals Inc recalls
6 notices naming Mylan Pharmaceuticals Inc as the recalling firm, since March 26, 2025. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Dissolution
Mylan Pharmaceuticals Inc: Carton label: Mycophenolate Mofetil for injection
Hazard (FDA): Failed Dissolution Specifications
FDAMedicines
Dissolution
Mylan Pharmaceuticals Inc: Prasugrel Tablets
Hazard (FDA): Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria
FDAMedicines
Dissolution
Mylan Pharmaceuticals Inc: Acamprosate Calcium
Hazard (FDA): Failed Dissolution Specifications
FDAMedicines
MYLAN PHARMACEUTICALS INC: Mycophenolate Mofetil for Injection USP
Hazard (FDA): Presence of precipitate
FDAMedicines
Dissolution
MYLAN PHARMACEUTICALS INC: Amnesteem
Hazard (FDA): Failed Dissolution Specifications
FDAMedicines
Dissolution
MYLAN PHARMACEUTICALS INC: Prasugrel Tablets
Hazard (FDA): Failed Dissolution Specifications - low dissolution results
FDAMedicines